Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Plasma and serum oxylipin, endocannabinoid, bile acid, steroid, fatty acid and nonsteroidal anti-inflammatory drug quantification in a 96-well plate format

Analytica Chimica Acta(2020)10.1016/j.aca.2020.11.019Source: DataRank Database

Plasma and serum oxylipin, endocannabinoid, bile acid, steroid, fatty acid and nonsteroidal anti-inflammatory drug quantification in a 96-well plate format is a research paper published in Analytica Chimica Acta (2020). On theSindex it has a DataRank of 0.612. It has been cited 58 times.

N/A

0.612DataRank · unranked

Scored on demand from live citation data

Open Access58 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (24 grants)Impact (FWCI 6.25)OA: greenTopics (77)Linked Datasets (12)DataCite Reuse (12)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.612

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (3)

Ira J. Gray ORCID,John W. Newman ORCID,Theresa L. Pedersen

Live enrichment

PubMed:33384117 OpenAlex:https://openalex.org/W3110079796

National Institutes of Health

Grant: U24 DK0971540

National Institute on Aging

Grant: P30AG10161

National Institute on Aging

Grant: R01AG046171

National Institute on Aging

Grant: R01AG059093

National Institute on Aging

Grant: R01AG16819

National Institute on Aging

Grant: R01AG17917

National Institute on Aging

Grant: RF1AG051550

National Institute on Aging

Grant: RF1AG057452

National Institute on Aging

Grant: RF1AG058942

National Institute on Aging

Grant: U01AG061359

National Institute on Aging

Grant: U01AG61356

National Institute on Aging

Grant: U19AG063744

U.S. Department of Agriculture

Grant: 2032-51530-022-00D

U.S. Department of Agriculture

Grant: 2032-51530-025-00D

National Institutes of Health

Grant: 3U01AG061356-02S1

Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets

National Institutes of Health

Grant: 1RF1AG058942-01

Gut Liver Brain Biochemical Axis in Alzheimer's Disease

National Institutes of Health

Grant: 1RF1AG059093-01

Metabolic Networks and Pathways Predictive of Sex Differences in AD Risk and Responsiveness to Treatment

National Institutes of Health

Grant: 1P30AG010161-01

SHORT-TERM STABILITY OF CLINICAL TESTS

National Institutes of Health

Grant: 1RF1AG057452-01

Metabolic Network Analysis of Biochemical Trajectories in Alzheimer's Disease

National Institutes of Health

Grant: 5R01AG046171-03

Metabolic Networks and Pathways in Alzheimer's Disease

National Institutes of Health

Grant: 5U19AG063744-02

Alzheimer's Gut Microbiome Project

NEFA

Duke University

Rush University

FWCI

6.25

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: cc-by

repositoryhttps://escholarship.org/uc/item/2r00f5ng

publisherhttps://api.elsevier.com/content/article/PII:S0003267020311430?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0003267020311430?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.aca.2020.11.019

Fields of Study

Pharmacogenetics and Drug MetabolismHormonal and reproductive studiesEicosanoids and Hypertension Pharmacology0301 basic medicine03 medical and health sciences0303 health sciencesAgedAnti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalBile Acids and SaltsChromatography, LiquidEndocannabinoidsFatty AcidsFemaleHumansMaleOxylipinsPharmaceutical PreparationsSteroidsTandem Mass Spectrometry

MeSH Terms

AgedAnti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalBile Acids and SaltsChromatography, LiquidPharmaceutical PreparationsFatty AcidsFemaleHumansMaleSteroidsTandem Mass SpectrometryOxylipinsEndocannabinoids

Keywords

ChemistryOxylipinPolyunsaturated fatty acidMetaboliteSteroidEicosapentaenoic acidBile acidArachidonic acidGlucuronidationChromatographyFatty acidHormoneBiochemistryEnzymeMicrosomemetabolic profilingHigh-throughputLipid MediatorsNist Srm 1950MaleAnti-Inflammatory Agents610Analytical ChemistryBile Acids and SaltsChemical engineeringTandem Mass SpectrometryNanotechnologyHumansOxylipinsNutritionAgedLiquidAnti-Inflammatory Agents, Non-SteroidalFatty Acids540Pharmaceutical PreparationsChemical SciencesFemaleSteroidsNon-SteroidalOther Chemical SciencesChromatography, LiquidEndocannabinoids

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 10 of Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer’s disease

10.6084/m9.figshare.16575423.v1figshare

Additional file 10 of Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer’s disease

10.6084/m9.figshare.16575423figshare

Additional file 11 of Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer’s disease

10.6084/m9.figshare.16575432.v1figshare

Additional file 11 of Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer’s disease

10.6084/m9.figshare.16575432figshare

Additional file 1 of Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer’s disease

10.6084/m9.figshare.16575435.v1figshare

Additional file 1 of Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer’s disease

10.6084/m9.figshare.16575435figshare

Additional file 2 of Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer’s disease

10.6084/m9.figshare.16575438.v1figshare

Additional file 2 of Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer’s disease

10.6084/m9.figshare.16575438figshare

Additional file 3 of Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer’s disease

10.6084/m9.figshare.16575441.v1figshare

Additional file 3 of Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer’s disease

10.6084/m9.figshare.16575441figshare

Additional file 9 of Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer’s disease

10.6084/m9.figshare.16575459.v1figshare

Additional file 9 of Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer’s disease

10.6084/m9.figshare.16575459figshare